These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34674346)

  • 21. [Cardioversion efficacy of nifekalan in patients with sustained atrial fibrillation after radiofrequency ablation].
    Li F; Xia Z; Yu JH; Chen Q; Hu JZ; Zhu B; Xia ZR; Huang QH; Li JX; Hong K; Wu YQ; Cheng XS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Dec; 47(12):963-968. PubMed ID: 31877591
    [No Abstract]   [Full Text] [Related]  

  • 22. Impact of Sinus Node Recovery Time after Long-Standing Atrial Fibrillation Termination on the Long-Term Outcome of Catheter Ablation.
    Yamaguchi N; Okumura Y; Watanabe I; Nagashima K; Takahashi K; Iso K; Watanabe R; Arai M; Mano H; Kogawa R; Kurokawa S; Ohkubo K; Nakai T; Hirayama A; Sonoda K; Tosaka T
    Int Heart J; 2018 May; 59(3):497-502. PubMed ID: 29743409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher burden of supraventricular ectopic complexes early after catheter ablation for atrial fibrillation is associated with increased risk of recurrent atrial fibrillation.
    Alhede C; Johannessen A; Dixen U; Jensen JS; Raatikainen P; Hindricks G; Walfridsson H; Kongstad O; Pehrson S; Englund A; Hartikainen J; Hansen PS; Nielsen JC; Jons C
    Europace; 2018 Jan; 20(1):50-57. PubMed ID: 28011799
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Elevated Left Atrial Pressure in Sinus Rhythm After Cardioversion on Outcomes After Catheter Ablation for Atrial Fibrillation.
    Kishima H; Mine T; Takahashi S; Ashida K; Ishihara M; Masuyama T
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):813-9. PubMed ID: 27090869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of the new target specific oral anticoagulants in the management of anticoagulation for cardioversion and atrial fibrillation ablation.
    Kowalski M; Parikh V
    J Thromb Thrombolysis; 2013 Aug; 36(2):175-86. PubMed ID: 23605999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Echocardiographic assessment of left atrial morphology and function to predict maintenance of sinus rhythm after electrical cardioversion in patients with non-valvular persistent atrial fibrillation and normal function or mild dysfunction of left ventricle.
    Wałek P; Sielski J; Starzyk K; Gorczyca I; Roskal-Wałek J; Wożakowska-Kapłon B
    Cardiol J; 2020; 27(3):246-253. PubMed ID: 31313277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Impact of Age on 5-Year Outcomes After Atrial Fibrillation Catheter Ablation.
    Bunch TJ; May HT; Bair TL; Jacobs V; Crandall BG; Cutler M; Weiss JP; Mallender C; Osborn JS; Anderson JL; Day JD
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):141-6. PubMed ID: 26443666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of Failed Electrical Cardioversion for Early Recurrence After Catheter Ablation for Atrial Fibrillation as a Predictor of Future Recurrence.
    Nakamaru R; Tanaka N; Okada M; Tanaka K; Ninomiya Y; Hirao Y; Oka T; Inoue H; Koyama Y; Okamura A; Iwakura K; Rakugi H; Sakata Y; Fujii K; Inoue K
    Am J Cardiol; 2019 Mar; 123(5):794-800. PubMed ID: 30558757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence and significance of early recurrences of atrial fibrillation after cryoballoon ablation: insights from the multicenter Sustained Treatment of Paroxysmal Atrial Fibrillation (STOP AF) Trial.
    Andrade JG; Khairy P; Macle L; Packer DL; Lehmann JW; Holcomb RG; Ruskin JN; Dubuc M
    Circ Arrhythm Electrophysiol; 2014 Feb; 7(1):69-75. PubMed ID: 24446022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biatrial enlargement as a predictor for reablation of atrial fibrillation.
    Kong Q; Shi L; Yu R; Long D; Zhang Y; Chen Y; Li J
    Int J Med Sci; 2020; 17(18):3031-3038. PubMed ID: 33173423
    [No Abstract]   [Full Text] [Related]  

  • 31. Age-Dependent Predictive Value of Endothelial Dysfunction for Arrhythmia Recurrence Following Pulmonary Vein Isolation.
    Matsuzawa Y; Suleiman M; Guddeti RR; Kwon TG; Monahan KH; Lerman LO; Friedman PA; Lerman A
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27613771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation in obstructive sleep apnea: Neural mechanisms and emerging therapies.
    Huang B; Liu H; Scherlag BJ; Sun L; Xing S; Xu J; Luo M; Guo Y; Cao G; Jiang H
    Trends Cardiovasc Med; 2021 Feb; 31(2):127-132. PubMed ID: 32008837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: A propensity-matched study of 24,244 patients.
    Noseworthy PA; Kapa S; Deshmukh AJ; Madhavan M; Van Houten H; Haas LR; Mulpuru SK; McLeod CJ; Asirvatham SJ; Friedman PA; Shah ND; Packer DL
    Heart Rhythm; 2015 Jun; 12(6):1154-61. PubMed ID: 25708883
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early direct current cardioversion or ablation for atrial fibrillation or atrial flutter and acute decompensated heart failure.
    Foo FS; Kerr A; Gabriel R; Heaven D; Looi JL; Lund M; Voss J; Sutton T
    N Z Med J; 2019 Jun; 132(1496):39-46. PubMed ID: 31170132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardioversion of persistent atrial fibrillation is associated with a 24-hour relapse gap: Observations from prolonged postcardioversion rhythm monitoring.
    Weijs B; Limantoro I; Delhaas T; de Vos CB; Blaauw Y; Houben RPM; Verheule S; Pisters R; Crijns HJGM
    Clin Cardiol; 2018 Mar; 41(3):366-371. PubMed ID: 29569353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnosis and management of atrial fibrillation: an overview.
    Romero I; Nedios S; Kriatselis C
    Cardiovasc Ther; 2014 Oct; 32(5):242-52. PubMed ID: 25130510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes after catheter ablation and cardioversion in patients with non-valvular atrial fibrillation: results from the prospective, observational XANTUS study.
    Camm AJ; Turpie AGG; Hess S; Amarenco P; Lambelet M; Haas S; van Eickels M; Kirchhof P;
    Europace; 2018 Jun; 20(6):e87-e95. PubMed ID: 29016755
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study.
    Badoz M; Serzian G; Favoulet B; Sellal JM; De Chillou C; Hammache N; Laurent G; Mebazaa A; Ecarnot F; Bardonnet K; Seronde MF; Schiele F; Meneveau N
    J Am Heart Assoc; 2021 Jul; 10(13):e020917. PubMed ID: 34187182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Post-shock sinus node recovery time is an independent predictor of recurrence after catheter ablation of longstanding persistent atrial fibrillation.
    Park J; Shim J; Uhm JS; Joung B; Lee MH; Pak HN
    Int J Cardiol; 2013 Oct; 168(3):1937-42. PubMed ID: 23380697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasively estimated left atrial stiffness is associated with short-term recurrence of atrial fibrillation after electrical cardioversion.
    Marino PN; Degiovanni A; Baduena L; Occhetta E; Dell'Era G; Erdei T; Fraser AG;
    J Cardiol; 2017 May; 69(5):731-738. PubMed ID: 27567175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.